Metropolitan Life Insurance Company (MetLife)’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,691
| Closed | -$61K | – | 567 |
|
|
2024
Q1 | $61K | Hold |
3,691
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q4 | $53.9K | Hold |
3,691
| – | – | ﹤0.01% | 1408 |
|
|
2023
Q3 | $45.3K | Buy |
3,691
+955
| +35% | +$11.7K | ﹤0.01% | 1458 |
|
|
2023
Q2 | $32.7K | Buy |
2,736
+1,192
| +77% | +$14.2K | ﹤0.01% | 1671 |
|
|
2023
Q1 | $20.6K | Sell |
1,544
-281
| -15% | -$3.76K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $39.3K | Hold |
1,825
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q3 | $36.6K | Hold |
1,825
| – | – | ﹤0.01% | 1675 |
|
|
2022
Q2 | $32.7K | Hold |
1,825
| – | – | ﹤0.01% | 1764 |
|
|
2022
Q1 | $18.1K | Buy |
+1,825
| New | +$18.1K | ﹤0.01% | 2137 |
|
|
2021
Q4 | – | Sell |
-3,636
| Closed | -$86.3K | – | 2796 |
|
|
2021
Q3 | $86.3K | Buy |
+3,636
| New | +$86.3K | ﹤0.01% | 2605 |
|